Skip to main content
. 2020 Nov 17;10:20012. doi: 10.1038/s41598-020-77075-1

Figure 5.

Figure 5

Progression-free survival and overall survival according to residual disease in FIGO stage III and IV (n = 47). (A) and (B): No gross residual vs. optimal vs. suboptimal. (C) and (D): No gross residual vs. Gross residual.